To evaluate the importance of CCDC106 in the invasion and EMT of ovarian cancers, Transwell migration assays and western blot analyses were performed after transfection with a CCDC106 plasmid or siRNA in mutant or wild-type p53 cells. This evidence concerns the gene TP53 and ovarian cancer.